Cosmopolitan Australia has closed… again. Less than two years after the iconic mag was relaunched in Australia, the outlet quietly closed over Christmas, with staff being told just last week. And ...

A SpaceX Falcon 9 rocket lifted off from Vandenberg Space Force Base in California, successfully launching COSMO-SkyMed CSG-FM3, the third second-generation satellite of Italy’s COSMO-SkyMed Earth ...

In 2025, Cosmopolitan sharpened its focus. We got clearer about what we wanted to look like, sound like, and do across our platforms. We treated legacy as a foundation, rather than a constraint. Our ...

Miss Philippines Chelsea Fernandez has been named first runner-up for Miss Cosmo 2025. On Saturday, Fernandez placed second during the Miss Cosmo 2025 Grand Finale & Beauty Music Festival held in Ho ...

Miss Cosmo International 2025 Yolina Lindquist and runner-up Chelsea Fernandez. Image from Miss Cosmo International Instagram Yolina Lindquist from the United States was crowned Miss Cosmo 2025 in ...

The Philippines’ Chelsea Fernandez (second from right) with (from left) Nguyen Hoang Phuong Linh, Beyonce Forbes, Kelin Rivera Kroll and Aexandria Mina. Image: Facebook/Miss Cosmo Chelsea Fernandez ...

MANILA, Philippines — Chelsea Fernandez is currently making waves as the country's representative at Miss Cosmo 2025 in Vietnam. The former Binibining Pilipinas Globe 2022 (and The Miss Globe 2022 Top ...

Images of the scalps of two patients treated with the 5% formulation of Cosmo Pharmaceuticals’ androgenetic alopecia (AGA) candidate clascoterone—both during their first visits, and their seventh ...

Cosmo Pharmaceuticals has revealed topline results from two phase 3 trials which indicate that its topical cream clascoterone could become a game-changing treatment for male-pattern hair loss. The ...

Shares of Cosmo Pharmaceuticals (OTCPK:CMOPF) soared as much as 24% in Zurich—the biggest jump since 2008—after the company said that its experimental male hair loss treatment met key endpoints in two ...

Investing.com -- Cosmo Pharmaceuticals ’ shares jumped more than 20% on Wednesday after the Swiss drugmaker reported that two Phase III trials of its hair-loss treatment Breezula met their co-primary ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.